Abstract
Hydroxyurea was used as a selective agent in culture, to isolate by a stepwise procedure, a unique mouse L cell line called LHF which exhibited a stable resistance to high concentrations of drug (5 mM). LHF cells contained an elevation in ribonucleotide reductase activity which depended upon whether cells were previously cultured in the presence or absence of hydroxyurea. M1 immunoprecipitation and M2 titration experiments indicated that both ribonucleotide reductase subunits were elevated in drug-resistant cells. Interestingly, a very large drug-dependent change in the M2 activity (about a 100-fold) was observed. Studies on enzyme activity with cycloheximide and actinomycin D indicated that the hydroxyurea-dependent increase in activity required de novo protein synthesis and transcriptional activity. These results are different from other ribonucleotide reductase overproducing cell lines previously described, and indicate that hydroxyurea modulates enzyme activity by an interesting mechanism.
Similar content being viewed by others
Literature cited
Thelander, L., and Reichard, P. (1979).Annu. Rev. Biochem. 48:133–158.
Cory, J.G., and Sato, A. (1983).Mol. Cell. Biochem. 53:257–266.
Wright, J.A. (1983).Pharmacol. Ther. 22:81–102.
Weber, G. (1983).Cancer Res. 43:3466–3492.
Tagger, A.Y., and Wright, J.A. (1984).Enzyme 32:142–148.
Ullman, B., Gudas, L.J., Clift, S.M., and Martin, D.W., jr. 1979).Proc. Natl. Acad. Sci. U.S.A. 76:1074–1078.
Weinberg, G., Ullman, B., and Martin, D.W., jr. (1981).Proc. Natl. Acad. Sci. U.S.A. 78:2447–2451.
Chan, V.I., Guttman, S., and Juranka, P. (1981).Mol. Cell. Biol. 1:568–571.
Dick, J.E., and Wright, J.A. (1984).Mech. Ageing Dev. 26:37–49.
Creasey, D.C., and Wright, J.A. (1984).Biosci. Rep. 4:299–309.
Moore, E.C. (1977).Adv. Enzyme Regul. 15:101–114.
Thelander, L., Eriksson, S., and Akerman, M. (1980).J. Biol. Chem. 255:7426–7432.
Akerblom, L., Ehrenberg, A., Graslund, A., Lankinen, H., Reichard, P., and Thelander, L. (1981).Proc. Natl. Acad. Sci. U.S.A. 78:2159–2163.
Eriksson, S., and Martin, D.W., Jr. (1981).J. Biol. Chem. 256:9436–9440.
Cory, J.G., and Fleischer, A.E. (1982).J. Biol. Chem. 257:1263–1266.
Wright, J.A., Lewis, W.H., and Parfett, C.L.J. (1980).Can. J. Genet. Cytol. 22:443–496.
Wright, J.A., Hards, R.G., and Dick, J.E. (1981).Adv. Enzyme Regul. 19:105–127.
Kuzik, B.A., and Wright, J.A. (1980).Biochem. Genet. 18:311–331.
Lewis, W.H., Kuzik, B.A., and Wright, J.A. (1978).J. Cell. Physiol. 94:287–298.
Hards, R.G., and Wright, J.A. (1983).Arch. Biochem. Biophys. 220:576–583.
Steeper, J.P., and Stuart, C.D. (1970).Anal. Biochem. 34:123–130.
Mattaliano, R.J., Sloan, A.M., Plumer, E.R., and Klippenstein, G.L. (1981).Biochem. Biophys. Res. Commun. 102:667–674.
Engstrom, Y., Eriksson, S., Thelander, L., and Akerman, M. (1979).Biochemistry 18:2941–2948.
Firestone, G.L., Payvan, F., and Yamamoto, K.R. (1982).Nature 300:221–225.
Caras, I.W., Levinson, B.B., Fabry, M., Williams, S.R., and Martin, D.W., Jr. (1985).J. Biol. Chem. 260:7015–7022.
Laemmli, U.K. (1970).Nature 227:680–682.
Lewis, W.H., and Srinivason, P.R. (1983).Mol. Cell. Biol. 3:1053–1061.
Eriksson, S., Thelander, L., and Akerman, M. (1979).Biochemistry 18:2948–2952.
Lewis, W.H., and Wright, J.A. (1979).Somat. Cell Genet. 5:83–96.
Stark, G.R., and Wahl, G.M. (1984).Annu. Rev. Biochem. 53:447–491.
Schimke, R.T. (1984).Cancer Res. 44:1735–1742.
Thelander, M., Graslund, A., and Thelander, L. (1985).J. Biol. Chem. 260:2737–2741.
Dedhar, S., Hartley, D., and Goldie, J.H. (1984).Biochem. J. 225:609–617.
Domin, B.A., Grill, S.P., Bastow, K.F., and Cheng, Y.-C. (1982).Mol. Pharmacol. 21:478–482.
Domin, B.A., Grill, S.P., and Cheng, Y.-C. (1983).Cancer Res. 43:2155–2158.
Eriksson, S., Thelander, L., and Akerman, M. (1979).Biochemistry 18:2948–2952.
Curt, G.A., Cowan, K.H., and Chabner, B.A. (1984).J. Clin. Oncol. 2:62–64.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McClarty, G.A., Chan, A.K.M. & Wright, J.A. Characterization of a mouse cell line selected for hydroxyurea resistance by a stepwise procedure: Drug-dependent overproduction of ribonucleotide reductase activity. Somat Cell Mol Genet 12, 121–131 (1986). https://doi.org/10.1007/BF01560659
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01560659